In our study, no significant difference in CD44 expression was observed between cc-RCC and non-ccRCC cases; however, significant differences existed in the degree of MMP-2 and MMP-9 expression between cc-RCC and non-ccRCC cases. This evidence concerns the gene CD44 and renal cell carcinoma.